Earnings Per Share (Tables)
|
3 Months Ended |
12 Months Ended |
Mar. 31, 2026 |
Dec. 31, 2025 |
| Earnings Per Share [Abstract] |
|
|
| Schedule of Earning Per Shares, Basic and Diluted |
The
schedule of loss per share, basic and diluted is as follows:
Schedule
of Earning Per Shares, Basic and Diluted
| For The Three Months Ended March 31, | |
2026 | | |
2025 | |
| Net loss | |
$ | (1,779,217 | ) | |
$ | (827,199 | ) |
| Deemed dividend on Series B Preferred Stock redemption | |
| (87,612 | ) | |
| - | |
| Net loss attributable to common stockholders | |
| (1,866,829 | ) | |
| (827,199 | ) |
| Weighted average shares outstanding – basic and diluted | |
| 4,353,099 | | |
| 2,786,538 | |
| Basic and diluted net loss per share | |
$ | (0.43 | ) | |
$ | (0.30 | ) |
|
The
schedule of loss per shares, basic and diluted is as follows:
Schedule of Earning Per Shares, Basic and Diluted
| For The Year
Ended December 31, | |
2025 | | |
2024 | |
| Net loss | |
$ | (2,160,998 | ) | |
$ | (48,319,475 | ) |
| Deemed dividend on Series B Preferred Stock redemption | |
| (241,435 | ) | |
| - | |
| Net loss attributable to common stockholders | |
| (2,402,433 | ) | |
| (48,319,475 | ) |
| Weighted average shares outstanding – basic and diluted | |
| 2,921,648 | | |
| 2,772,867 | |
| Basic and diluted net loss per share | |
$ | (0.82 | ) | |
$ | (17.43 | ) |
|
| Schedule of Weighted Average Shares Outstanding - Basic and Diluted |
The
following is a schedule of the weighted average shares outstanding, basic and diluted, for the three months ended March 31,
2026 and March 31, 2025, respectively.
Schedule
of Weighted Average Shares Outstanding - Basic and Diluted
| | |
Three Months Ended March 31, | |
| Weighted Average Shares Calculation – Basic and Diluted | |
2026 | | |
2025 | |
| Weighted average shares | |
| 4,353,099 | | |
| 2,786,538 | |
|
The
following is a schedule of the weighted average shares outstanding - basic and diluted, for the year ended December 31, 2025 and December
31, 2024.
Schedule of Weighted Average Shares Outstanding - Basic and Diluted
| | |
2025 | | |
2024 | |
| Weighted
Average Shares Calculation – Basic and Diluted | |
Year
Ended December
31, | |
| | |
2025 | | |
2024 | |
| Weighted average shares | |
| 2,921,648 | | |
| 2,772,867 | |
|
| Schedule of Share-based Equity Awards and Warrants Excluded from Computation of Earnings |
Schedule
of Share-based Equity Awards and Warrants Excluded from Computation of Earnings
| | |
2026 | | |
2025 | |
| | |
Three Months Ended March 31, | |
| | |
2026 | | |
2025 | |
| Shares to be issued to Abaca shareholders | |
| - | | |
| 37,500 | |
| Stock options | |
| 538,618 | | |
| 214,824 | |
| Conversion of Series B Convertible Preferred Stock | |
| 19,840,289 | | |
| - | |
| Conversion of preferred stock | |
| 4,440 | | |
| 4,440 | |
| Warrants | |
| 10,521,974 | | |
| 601,829 | |
| Total | |
| 30,905,321 | | |
| 858,593 | |
|
Schedule of Share-based Equity Awards and Warrants Excluded from Computation of Earnings
| | |
2025 | | |
2024 | |
| | |
Year
Ended December
31, | |
| | |
2025 | | |
2024 | |
| Shares to be issued to Abaca shareholders | |
| - | | |
| 37,500 | |
| Stock options | |
| 538,618 | | |
| 113,673 | |
| Conversion of Series B Convertible Preferred
Stock | |
| 3,999,291 | | |
| - | |
| Conversion of preferred stock | |
| 4,440 | | |
| 4,440 | |
| Warrants | |
| 2,601,374 | | |
| 601,829 | |
| Total | |
| 7,112,296 | | |
| 757,442 | |
|